Bio-Rad Laboratories Inc Cash Flow Conversion Efficiency
Bio-Rad Laboratories Inc cash flow conversion efficiency. Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO) has a cash flow conversion efficiency ratio of 0.014x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($98.70 Million) by net assets ($7.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bio-Rad Laboratories Inc (1989–2025)
Cash flow conversion efficiency of Bio-Rad Laboratories Inc from 1989 to 2025. This chart illustrates how Bio-Rad Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bio-Rad Laboratories Inc share price for real-time trading data and today's change.
Bio-Rad Laboratories Inc Cash Flow Conversion Ratio Explained
Bio-Rad Laboratories Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bio-Rad Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their cash flow conversion efficiency. Also see Bio-Rad Laboratories Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MGM Resorts International
NYSE:MGM
|
0.170x |
|
UNO Minda Limited
NSE:UNOMINDA
|
0.093x |
|
Dixon Technologies (India) Limited
NSE:DIXON
|
0.044x |
|
RATIONAL Aktiengesellschaft
XETRA:RAA
|
0.126x |
|
Meridian Energy Ltd
AU:MEZ
|
0.038x |
|
Lotus Bakeries
BR:LOTB
|
0.090x |
|
Murphy USA Inc
NYSE:MUSA
|
0.394x |
|
Descartes Systems Group Inc
TO:DSG
|
0.048x |
Annual Cash Flow Conversion Efficiency for Bio-Rad Laboratories Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Rad Laboratories Inc from 1989 to 2025. Review BIO free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.45 Billion | $532.20 Million | 0.071x | +3.04% |
| 2024-12-31 | $6.57 Billion | $455.20 Million | 0.069x | +61.54% |
| 2023-12-31 | $8.74 Billion | $374.94 Million | 0.043x | +112.11% |
| 2022-12-31 | $9.62 Billion | $194.45 Million | 0.020x | -57.85% |
| 2021-12-31 | $13.69 Billion | $656.52 Million | 0.048x | -18.98% |
| 2020-12-31 | $9.88 Billion | $584.97 Million | 0.059x | -25.58% |
| 2019-12-31 | $5.76 Billion | $457.90 Million | 0.080x | +12.04% |
| 2018-12-31 | $4.02 Billion | $285.49 Million | 0.071x | +99.82% |
| 2017-12-31 | $2.93 Billion | $104.14 Million | 0.036x | -57.58% |
| 2016-12-31 | $2.58 Billion | $216.07 Million | 0.084x | +12.04% |
| 2015-12-31 | $2.49 Billion | $186.21 Million | 0.075x | -40.22% |
| 2014-12-31 | $2.19 Billion | $273.31 Million | 0.125x | +61.71% |
| 2013-12-31 | $2.19 Billion | $169.14 Million | 0.077x | -41.50% |
| 2012-12-31 | $2.02 Billion | $266.48 Million | 0.132x | -12.22% |
| 2011-12-31 | $1.74 Billion | $262.74 Million | 0.151x | +2.71% |
| 2010-12-31 | $1.54 Billion | $225.91 Million | 0.147x | -42.29% |
| 2009-12-31 | $1.28 Billion | $325.07 Million | 0.254x | +42.17% |
| 2008-12-31 | $1.07 Billion | $191.37 Million | 0.179x | -9.34% |
| 2007-12-31 | $971.69 Million | $191.58 Million | 0.197x | +36.67% |
| 2006-12-31 | $819.54 Million | $118.23 Million | 0.144x | -12.34% |
| 2005-12-31 | $657.97 Million | $108.28 Million | 0.165x | -20.20% |
| 2004-12-31 | $596.89 Million | $123.09 Million | 0.206x | -19.89% |
| 2003-12-31 | $495.81 Million | $127.64 Million | 0.257x | -6.75% |
| 2002-12-31 | $383.09 Million | $105.76 Million | 0.276x | -21.23% |
| 2001-12-31 | $283.88 Million | $99.50 Million | 0.350x | +253.59% |
| 2000-12-31 | $244.62 Million | $24.25 Million | 0.099x | -51.52% |
| 1999-12-31 | $220.10 Million | $45.00 Million | 0.204x | +60.49% |
| 1998-12-31 | $214.30 Million | $27.30 Million | 0.127x | +18.76% |
| 1997-12-31 | $196.70 Million | $21.10 Million | 0.107x | -40.71% |
| 1996-12-31 | $183.50 Million | $33.20 Million | 0.181x | -25.59% |
| 1995-12-31 | $157.10 Million | $38.20 Million | 0.243x | -34.65% |
| 1994-12-31 | $129.80 Million | $48.30 Million | 0.372x | +82.42% |
| 1993-12-31 | $110.30 Million | $22.50 Million | 0.204x | +446.18% |
| 1992-12-31 | $107.10 Million | $4.00 Million | 0.037x | -17.29% |
| 1991-12-31 | $90.80 Million | $4.10 Million | 0.045x | -69.74% |
| 1990-12-31 | $81.10 Million | $12.10 Million | 0.149x | +4.90% |
| 1989-12-31 | $68.90 Million | $9.80 Million | 0.142x | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more